How can you ensure your glycomics data originates from precise sources? CD BioGlyco provides the answer with its newly upgraded glycan release service. We focus on this critical step that determines the success of subsequent analyses. Through systematic process optimization and standardized operations, coupled with rigorous quality control throughout, we aim to minimize initial errors. We deliver highly consistent and faithful release results, establishing a solid foundation for advanced glycomics research.

Glycans are attached to proteins or lipids through various chemical bonds, and their structures are inherently highly complex and heterogeneous. This characteristic makes the release process challenging:

Risk to Structural Integrity: Improper release conditions (e.g., enzyme selection, reaction time, pH) may lead to partial cleavage of sugar chains, non-specific modifications, or selective loss of specific glycan types, thereby distorting the true biological information.

Difficulty in Data Reproducibility: Even minor variations in experimental conditions can make results difficult to compare directly across different laboratories or experimental batches, severely hindering the validation and integration of scientific discoveries.

Dilemma in Method Selection: Enzymatic methods (e.g., PNGase F) offer high specificity and can release intact glycans with specific linkages (e.g., N-linked), but their application scope is limited. Chemical methods (e.g., hydrazinolysis) have a broader range of applications but require extremely fine-tuned optimization to minimize side reactions.

Solution: Professional and Customized Release Strategies

To address these challenges, CD BioGlyco emphasizes that the upgrade of this new Glycan Release Service offers a variety of rigorously validated release protocols. This ensures the most suitable technical pathway is matched to different research objectives and sample types.

Below are descriptions of some protocols:

To ensure the integrity of sugar chain structures and analytical reliability, CD BioGlyco offers high-fidelity enzymatic release services. This service employs precise, gentle enzymatic processes and encompasses the following core projects:

l N-Glycan Release: Utilizes high-purity PNGase F to efficiently and reproducibly release intact N-linked glycans from complex glycoproteins. This serves as the standard starting point for glycoform analysis of antibody-based therapeutics and many fundamental studies.

l O-Glycan Release: Employs enzyme combinations, including O-glycosidase, to gently and effectively release O-linked glycans. This is particularly suitable for structural studies involving enzyme-sensitive structures.

l Specific Monosaccharide Release: CD BioGlyco provides specific enzymatic release services targeting terminally modified monosaccharides (e.g., fucose, sialic acid, galactose). For instance, precise removal of sialic acid using sialidase is crucial for studying its role in immune recognition and cell communication.

Enzymatic methods offer precision, yet their applicability remains limited. When dealing with complex glycoforms beyond the reach of these methods, or scenarios requiring the simultaneous processing of multiple glycan types, researchers often face a dilemma. In such cases, a deeply optimized chemical release strategy becomes the critical pathway.

CD BioGlyco's experience in this field demonstrates that through millimeter-level fine-tuning of reaction conditions, chemical methods can achieve both efficient and broad-spectrum glycan release while preserving structural integrity to the greatest extent, thereby paving the way for subsequent high-precision analysis.

“Glycomics as a field is concentrating more and more on refinement and systematization, and the field is really being driven by the need for standardized glycan release methodologies for quality data,” said Anna, project leader at CD BioGlyco. “With more than 20 years of glycoscience experience, the release of glycans is the most reliable and methodical service we have to offer. We intend to provide methodological and result-driven reliable support to researchers worldwide. We hope to collaborate with our academic peers and advance glycobiology.”